Richard A. Colvin - 30 Sep 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Chief Medical Officer
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
30 Sep 2024
Net transactions value
$0
Form type
4
Filing time
02 Oct 2024, 16:06:56 UTC
Previous filing
05 Mar 2024
Next filing
12 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +50,000 +42% $0.000000 168,368 30 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units for common stock vest over a four-year period at the rate of 25% on each of March 1, 2025, March 1, 2026, March 1, 2027 and March 1, 2028. These restricted stock units were approved during the Issuer's regular annual review cycle for 2024 with a delayed date of issuance.